HORIZON THERAPEUTICS IRELAND DAC
BiotechHORIZON THERAPEUTICS IRELAND DAC is a biotechnology company with 1 FDA-approved products.
HORIZON THERAPEUTICS IRELAND DAC's Key Drugs
HORIZON THERAPEUTICS IRELAND DAC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
HORIZON THERAPEUTICS IRELAND DAC's Recent FDA Approvals
New NDA/BLA approvals for HORIZON THERAPEUTICS IRELAND DAC over the last two years — novel drugs only, excluding generics and label supplements.
HORIZON THERAPEUTICS IRELAND DAC's Therapeutic Areas
Disease areas where HORIZON THERAPEUTICS IRELAND DAC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
HORIZON THERAPEUTICS IRELAND DAC Pipeline Snapshot
Active clinical trials for HORIZON THERAPEUTICS IRELAND DAC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1999-02-25
- Latest
- 2015-08-27
- Applications
- 1